ArticleBioscience reports2024

Retraction: Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.